Patent · US Active

Acyclic antivirals

US10745427B2 · kind B2 · utility

3Cited by

1References

19Claims

0Family size

Assignee

Janssen BioPharma, Inc. · US

Inventors

Leonid Beigelman · San Mateo, US
Guangyi Wang · Carlsbad, US
Minghong Zhong · Lo Wu, CN

Key dates

Filing date	Mar 9, 2017
Grant date	Aug 18, 2020
Priority date	—
Expiry date	Mar 9, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61F2013/51026
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HBV and/or HDV and/or HIV infection with one or more nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.